We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ISSUES GUIDANCE ON DEVELOPING IMAGING AGENTS
FDA ISSUES GUIDANCE ON DEVELOPING IMAGING AGENTS
June 18, 2004
The FDA released a three-part final guidance last week to help manufacturers with the application process for medical imaging drugs and biological products used to diagnose and monitor diseases or conditions.